Pefloxacin Mesilate

甲磺酸培氟沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NamePefloxacin Mesilate
Drug Alias Name培氟甲氟哌酸PefloxacinoPefloxacinum甲磺酸培氟哌酸Pefloxacin mesylate +[9
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsCommunicable Diseases
Approved Indications in ChinaCommunicable Diseases
Original Approved Country/TerritoryFrance
Original Approved Date1985/01/01
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeJ01MA03